Discovery Services

The ability to rule out unsuitable drug candidates in the preclinical discovery process is key in the development of any therapeutic. Charles River has developed and streamlined its global discovery capabilities to meet the rapid timelines and diverse needs required for the most efficient drug candidate ranking and selection process. We offer a “single point of contact” approach, which yields timely and effective communications plus an innovative and solution-focused partnership for your discovery programs.

Recognized throughout the industry for its expertise, Charles River’s discovery team excels in conducting discovery studies ranging from in vitro ADMET, rapid pharmacokinetic screening, and bioanalysis to PK/ADME and pharmacology. The majority of our discovery services programs can be transitioned to follow Good Laboratory Practices (GLP) if required.

What's New

All news items

 Charles River Home | Careers | Humane Care | Events | News Room | Investor Relations | Site Index | Contact